Since the first use of coronary angioplasty in 1977, there have been major growth and development in percutaneous coronary intervention (PCI). Due to the advances in techniques, experiences, devices, and newer potent antiplatelet and antithrombotic medications, PCI is increasingly performed in highly complex and high risk patients with a reasonably low complication rate. Coupled with reduced discomfort, shorter hospital stay and recovery time, it has far outnumbered the volume of coronary artery bypass surgery. Currently, 1.7 million PCI procedures are performed annually worldwide with increases by 15-20% per year the last decade.
Yuk-Kong Lau, Drug Eluting Stent: A Major Advance in Fighting Coronary Artery Restenosis Journal of the Hong Kong College of Cardiology 2002;10(4) https://doi.org/10.55503/2790-6744.1196